Clinical Trial Update: A Phase 1, Randomized, Placebo-controlled, Multiple Dose Escalation Study to Investigate Safety, Pharmacokinetics, and Pharmacodynamics of SHR0534 in Chinese Type 2 Diabetic Patients [Phase 1]

View source ↗

Summary

A Phase 1 randomized, placebo-controlled, multiple-dose escalation study assessing safety, pharmacokinetics, and pharmacodynamics of SHR0534 in Chinese adults w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SHR0534

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Type 2 Diabetic Patients | Phase 1 | Status: COMPLETED